BDI Pharma Announces SAP “Go Live”

Share Article

BDI Pharma concludes SAP transition; system offers increased capabilities and efficiency for distribution.

BDI Pharma's Columbia, SC Headquarters

The final implementation of the live system represents the culmination of a company-wide project which will provide the additional efficiency, flexibility and capability to maintain the momentum that is propelling BDI Pharma forward at a record pace.

BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced that effective January 2, 2012 the company will officially go live with its new operating system, completing the transition to SAP as its ERP & Customer Relationship Management system solution.

“We view the company’s investment of time, resources and finances over the past months as necessary and vital to the growth of BDI Pharma,” stated Thomas Draughn, BDI’s SAP Project Manager. “The final implementation of the live system represents the culmination of a company-wide project which will provide the additional efficiency, flexibility and capability to maintain the momentum that is propelling BDI Pharma forward at a record pace.”

About BDI Pharma, Inc.

Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs for specialty veterinarians -- 4legpharma.com; product consignment -- consignadvantage.com; flu pre-booking and general vaccine ordering -- securivax.com; and purchasing/reward programs -- qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.

BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brad Davis
Visit website